December 7, 2011
written by Michael O’Leary
More people with type 2 diabetes using insulin and metformin who have trouble keeping their blood glucose below 8 percent are able to reach their goal if they take lixisenatide with insulin and metformin.
That’s the interim result of the GetGoal Duo 1 study announced today in a press release by Sanofi Aventis, which has the marketing rights to the drug made by Zealand Pharma. (Link to published site)
